Global CD47 (IAP) Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global CD47 (IAP) Market Size 2017-2028

2.1.2 CD47 (IAP) Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 CD47 (IAP) Segment by Type

2.2.1 CD47 Monoclonal Antibody

2.2.2 CD47 Double Antibody

2.2.3 CD47 Fusion Protein

2.3 CD47 (IAP) Market Size by Type

2.3.1 CD47 (IAP) Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global CD47 (IAP) Market Size Market Share by Type (2017-2022)

2.4 CD47 (IAP) Segment by Application

2.4.1 Solid Tumor

2.4.2 Lymphoma

2.4.3 Others

2.5 CD47 (IAP) Market Size by Application

2.5.1 CD47 (IAP) Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global CD47 (IAP) Market Size Market Share by Application (2017-2022)

3 CD47 (IAP) Market Size by Player

3.1 CD47 (IAP) Market Size Market Share by Players

3.1.1 Global CD47 (IAP) Revenue by Players (2020-2022)

3.1.2 Global CD47 (IAP) Revenue Market Share by Players (2020-2022)

3.2 Global CD47 (IAP) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 CD47 (IAP) by Regions

4.1 CD47 (IAP) Market Size by Regions (2017-2022)

4.2 Americas CD47 (IAP) Market Size Growth (2017-2022)

4.3 APAC CD47 (IAP) Market Size Growth (2017-2022)

4.4 Europe CD47 (IAP) Market Size Growth (2017-2022)

4.5 Middle East & Africa CD47 (IAP) Market Size Growth (2017-2022)

5 Americas

5.1 Americas CD47 (IAP) Market Size by Country (2017-2022)

5.2 Americas CD47 (IAP) Market Size by Type (2017-2022)

5.3 Americas CD47 (IAP) Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC CD47 (IAP) Market Size by Region (2017-2022)

6.2 APAC CD47 (IAP) Market Size by Type (2017-2022)

6.3 APAC CD47 (IAP) Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe CD47 (IAP) by Country (2017-2022)

7.2 Europe CD47 (IAP) Market Size by Type (2017-2022)

7.3 Europe CD47 (IAP) Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa CD47 (IAP) by Region (2017-2022)

8.2 Middle East & Africa CD47 (IAP) Market Size by Type (2017-2022)

8.3 Middle East & Africa CD47 (IAP) Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global CD47 (IAP) Market Forecast

10.1 Global CD47 (IAP) Forecast by Regions (2023-2028)

10.1.1 Global CD47 (IAP) Forecast by Regions (2023-2028)

10.1.2 Americas CD47 (IAP) Forecast

10.1.3 APAC CD47 (IAP) Forecast

10.1.4 Europe CD47 (IAP) Forecast

10.1.5 Middle East & Africa CD47 (IAP) Forecast

10.2 Americas CD47 (IAP) Forecast by Country (2023-2028)

10.2.1 United States CD47 (IAP) Market Forecast

10.2.2 Canada CD47 (IAP) Market Forecast

10.2.3 Mexico CD47 (IAP) Market Forecast

10.2.4 Brazil CD47 (IAP) Market Forecast

10.3 APAC CD47 (IAP) Forecast by Region (2023-2028)

10.3.1 China CD47 (IAP) Market Forecast

10.3.2 Japan CD47 (IAP) Market Forecast

10.3.3 Korea CD47 (IAP) Market Forecast

10.3.4 Southeast Asia CD47 (IAP) Market Forecast

10.3.5 India CD47 (IAP) Market Forecast

10.3.6 Australia CD47 (IAP) Market Forecast

10.4 Europe CD47 (IAP) Forecast by Country (2023-2028)

10.4.1 Germany CD47 (IAP) Market Forecast

10.4.2 France CD47 (IAP) Market Forecast

10.4.3 UK CD47 (IAP) Market Forecast

10.4.4 Italy CD47 (IAP) Market Forecast

10.4.5 Russia CD47 (IAP) Market Forecast

10.5 Middle East & Africa CD47 (IAP) Forecast by Region (2023-2028)

10.5.1 Egypt CD47 (IAP) Market Forecast

10.5.2 South Africa CD47 (IAP) Market Forecast

10.5.3 Israel CD47 (IAP) Market Forecast

10.5.4 Turkey CD47 (IAP) Market Forecast

10.5.5 GCC Countries CD47 (IAP) Market Forecast

10.6 Global CD47 (IAP) Forecast by Type (2023-2028)

10.7 Global CD47 (IAP) Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Gilead

11.1.1 Gilead Company Information

11.1.2 Gilead CD47 (IAP) Product Offered

11.1.3 Gilead CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Gilead Main Business Overview

11.1.5 Gilead Latest Developments

11.2 Innovent Biologics

11.2.1 Innovent Biologics Company Information

11.2.2 Innovent Biologics CD47 (IAP) Product Offered

11.2.3 Innovent Biologics CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Innovent Biologics Main Business Overview

11.2.5 Innovent Biologics Latest Developments

11.3 Akeso, Inc

11.3.1 Akeso, Inc Company Information

11.3.2 Akeso, Inc CD47 (IAP) Product Offered

11.3.3 Akeso, Inc CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Akeso, Inc Main Business Overview

11.3.5 Akeso, Inc Latest Developments

11.4 Arch Oncology

11.4.1 Arch Oncology Company Information

11.4.2 Arch Oncology CD47 (IAP) Product Offered

11.4.3 Arch Oncology CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Arch Oncology Main Business Overview

11.4.5 Arch Oncology Latest Developments

11.5 ImmuneOncia Therapeutics

11.5.1 ImmuneOncia Therapeutics Company Information

11.5.2 ImmuneOncia Therapeutics CD47 (IAP) Product Offered

11.5.3 ImmuneOncia Therapeutics CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 ImmuneOncia Therapeutics Main Business Overview

11.5.5 ImmuneOncia Therapeutics Latest Developments

11.6 I-MAB

11.6.1 I-MAB Company Information

11.6.2 I-MAB CD47 (IAP) Product Offered

11.6.3 I-MAB CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 I-MAB Main Business Overview

11.6.5 I-MAB Latest Developments

11.7 Sorrento Therapeutics

11.7.1 Sorrento Therapeutics Company Information

11.7.2 Sorrento Therapeutics CD47 (IAP) Product Offered

11.7.3 Sorrento Therapeutics CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Sorrento Therapeutics Main Business Overview

11.7.5 Sorrento Therapeutics Latest Developments

11.8 Zai Lab

11.8.1 Zai Lab Company Information

11.8.2 Zai Lab CD47 (IAP) Product Offered

11.8.3 Zai Lab CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Zai Lab Main Business Overview

11.8.5 Zai Lab Latest Developments

11.9 ImmuneOnco

11.9.1 ImmuneOnco Company Information

11.9.2 ImmuneOnco CD47 (IAP) Product Offered

11.9.3 ImmuneOnco CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 ImmuneOnco Main Business Overview

11.9.5 ImmuneOnco Latest Developments

11.10 Hengrui

11.10.1 Hengrui Company Information

11.10.2 Hengrui CD47 (IAP) Product Offered

11.10.3 Hengrui CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Hengrui Main Business Overview

11.10.5 Hengrui Latest Developments

11.11 Beijing Mab-works

11.11.1 Beijing Mab-works Company Information

11.11.2 Beijing Mab-works CD47 (IAP) Product Offered

11.11.3 Beijing Mab-works CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Beijing Mab-works Main Business Overview

11.11.5 Beijing Mab-works Latest Developments

11.12 Hanxbio

11.12.1 Hanxbio Company Information

11.12.2 Hanxbio CD47 (IAP) Product Offered

11.12.3 Hanxbio CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Hanxbio Main Business Overview

11.12.5 Hanxbio Latest Developments

11.13 ALX Oncology

11.13.1 ALX Oncology Company Information

11.13.2 ALX Oncology CD47 (IAP) Product Offered

11.13.3 ALX Oncology CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 ALX Oncology Main Business Overview

11.13.5 ALX Oncology Latest Developments

11.14 Surface Oncology

11.14.1 Surface Oncology Company Information

11.14.2 Surface Oncology CD47 (IAP) Product Offered

11.14.3 Surface Oncology CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Surface Oncology Main Business Overview

11.14.5 Surface Oncology Latest Developments

11.15 TG Therapeutics

11.15.1 TG Therapeutics Company Information

11.15.2 TG Therapeutics CD47 (IAP) Product Offered

11.15.3 TG Therapeutics CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 TG Therapeutics Main Business Overview

11.15.5 TG Therapeutics Latest Developments

11.16 EpicentRx

11.16.1 EpicentRx Company Information

11.16.2 EpicentRx CD47 (IAP) Product Offered

11.16.3 EpicentRx CD47 (IAP) Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 EpicentRx Main Business Overview

11.16.5 EpicentRx Latest Developments

12 Research Findings and Conclusion

Table 1. CD47 (IAP) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CD47 Monoclonal Antibody

Table 3. Major Players of CD47 Double Antibody

Table 4. Major Players of CD47 Fusion Protein

Table 5. CD47 (IAP) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 6. Global CD47 (IAP) Market Size by Type (2017-2022) & ($ Millions)

Table 7. Global CD47 (IAP) Market Size Market Share by Type (2017-2022)

Table 8. CD47 (IAP) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global CD47 (IAP) Market Size by Application (2017-2022) & ($ Millions)

Table 10. Global CD47 (IAP) Market Size Market Share by Application (2017-2022)

Table 11. Global CD47 (IAP) Revenue by Players (2020-2022) & ($ Millions)

Table 12. Global CD47 (IAP) Revenue Market Share by Player (2020-2022)

Table 13. CD47 (IAP) Key Players Head office and Products Offered

Table 14. CD47 (IAP) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 15. New Products and Potential Entrants

Table 16. Mergers & Acquisitions, Expansion

Table 17. Global CD47 (IAP) Market Size by Regions 2017-2022 & ($ Millions)

Table 18. Global CD47 (IAP) Market Size Market Share by Regions (2017-2022)

Table 19. Americas CD47 (IAP) Market Size by Country (2017-2022) & ($ Millions)

Table 20. Americas CD47 (IAP) Market Size Market Share by Country (2017-2022)

Table 21. Americas CD47 (IAP) Market Size by Type (2017-2022) & ($ Millions)

Table 22. Americas CD47 (IAP) Market Size Market Share by Type (2017-2022)

Table 23. Americas CD47 (IAP) Market Size by Application (2017-2022) & ($ Millions)

Table 24. Americas CD47 (IAP) Market Size Market Share by Application (2017-2022)

Table 25. APAC CD47 (IAP) Market Size by Region (2017-2022) & ($ Millions)

Table 26. APAC CD47 (IAP) Market Size Market Share by Region (2017-2022)

Table 27. APAC CD47 (IAP) Market Size by Type (2017-2022) & ($ Millions)

Table 28. APAC CD47 (IAP) Market Size Market Share by Type (2017-2022)

Table 29. APAC CD47 (IAP) Market Size by Application (2017-2022) & ($ Millions)

Table 30. APAC CD47 (IAP) Market Size Market Share by Application (2017-2022)

Table 31. Europe CD47 (IAP) Market Size by Country (2017-2022) & ($ Millions)

Table 32. Europe CD47 (IAP) Market Size Market Share by Country (2017-2022)

Table 33. Europe CD47 (IAP) Market Size by Type (2017-2022) & ($ Millions)

Table 34. Europe CD47 (IAP) Market Size Market Share by Type (2017-2022)

Table 35. Europe CD47 (IAP) Market Size by Application (2017-2022) & ($ Millions)

Table 36. Europe CD47 (IAP) Market Size Market Share by Application (2017-2022)

Table 37. Middle East & Africa CD47 (IAP) Market Size by Region (2017-2022) & ($ Millions)

Table 38. Middle East & Africa CD47 (IAP) Market Size Market Share by Region (2017-2022)

Table 39. Middle East & Africa CD47 (IAP) Market Size by Type (2017-2022) & ($ Millions)

Table 40. Middle East & Africa CD47 (IAP) Market Size Market Share by Type (2017-2022)

Table 41. Middle East & Africa CD47 (IAP) Market Size by Application (2017-2022) & ($ Millions)

Table 42. Middle East & Africa CD47 (IAP) Market Size Market Share by Application (2017-2022)

Table 43. Key Market Drivers & Growth Opportunities of CD47 (IAP)

Table 44. Key Market Challenges & Risks of CD47 (IAP)

Table 45. Key Industry Trends of CD47 (IAP)

Table 46. Global CD47 (IAP) Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 47. Global CD47 (IAP) Market Size Market Share Forecast by Regions (2023-2028)

Table 48. Global CD47 (IAP) Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 49. Global CD47 (IAP) Market Size Market Share Forecast by Type (2023-2028)

Table 50. Global CD47 (IAP) Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 51. Global CD47 (IAP) Market Size Market Share Forecast by Application (2023-2028)

Table 52. Gilead Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 53. Gilead CD47 (IAP) Product Offered

Table 54. Gilead CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 55. Gilead Main Business

Table 56. Gilead Latest Developments

Table 57. Innovent Biologics Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 58. Innovent Biologics CD47 (IAP) Product Offered

Table 59. Innovent Biologics Main Business

Table 60. Innovent Biologics CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 61. Innovent Biologics Latest Developments

Table 62. Akeso, Inc Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 63. Akeso, Inc CD47 (IAP) Product Offered

Table 64. Akeso, Inc Main Business

Table 65. Akeso, Inc CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 66. Akeso, Inc Latest Developments

Table 67. Arch Oncology Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 68. Arch Oncology CD47 (IAP) Product Offered

Table 69. Arch Oncology Main Business

Table 70. Arch Oncology CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 71. Arch Oncology Latest Developments

Table 72. ImmuneOncia Therapeutics Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 73. ImmuneOncia Therapeutics CD47 (IAP) Product Offered

Table 74. ImmuneOncia Therapeutics Main Business

Table 75. ImmuneOncia Therapeutics CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 76. ImmuneOncia Therapeutics Latest Developments

Table 77. I-MAB Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 78. I-MAB CD47 (IAP) Product Offered

Table 79. I-MAB Main Business

Table 80. I-MAB CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 81. I-MAB Latest Developments

Table 82. Sorrento Therapeutics Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 83. Sorrento Therapeutics CD47 (IAP) Product Offered

Table 84. Sorrento Therapeutics Main Business

Table 85. Sorrento Therapeutics CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 86. Sorrento Therapeutics Latest Developments

Table 87. Zai Lab Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 88. Zai Lab CD47 (IAP) Product Offered

Table 89. Zai Lab Main Business

Table 90. Zai Lab CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 91. Zai Lab Latest Developments

Table 92. ImmuneOnco Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 93. ImmuneOnco CD47 (IAP) Product Offered

Table 94. ImmuneOnco Main Business

Table 95. ImmuneOnco CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 96. ImmuneOnco Latest Developments

Table 97. Hengrui Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 98. Hengrui CD47 (IAP) Product Offered

Table 99. Hengrui Main Business

Table 100. Hengrui CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 101. Hengrui Latest Developments

Table 102. Beijing Mab-works Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 103. Beijing Mab-works CD47 (IAP) Product Offered

Table 104. Beijing Mab-works CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 105. Beijing Mab-works Main Business

Table 106. Beijing Mab-works Latest Developments

Table 107. Hanxbio Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 108. Hanxbio CD47 (IAP) Product Offered

Table 109. Hanxbio Main Business

Table 110. Hanxbio CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 111. Hanxbio Latest Developments

Table 112. ALX Oncology Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 113. ALX Oncology CD47 (IAP) Product Offered

Table 114. ALX Oncology Main Business

Table 115. ALX Oncology CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 116. ALX Oncology Latest Developments

Table 117. Surface Oncology Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 118. Surface Oncology CD47 (IAP) Product Offered

Table 119. Surface Oncology Main Business

Table 120. Surface Oncology CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 121. Surface Oncology Latest Developments

Table 122. TG Therapeutics Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 123. TG Therapeutics CD47 (IAP) Product Offered

Table 124. TG Therapeutics Main Business

Table 125. TG Therapeutics CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 126. TG Therapeutics Latest Developments

Table 127. EpicentRx Details, Company Type, CD47 (IAP) Area Served and Its Competitors

Table 128. EpicentRx CD47 (IAP) Product Offered

Table 129. EpicentRx Main Business

Table 130. EpicentRx CD47 (IAP) Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 131. EpicentRx Latest Developments

List of Figures

Figure 1. CD47 (IAP) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global CD47 (IAP) Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global CD47 (IAP) Market Size Market Share by Type in 2021

Figure 7. CD47 (IAP) in Solid Tumor

Figure 8. Global CD47 (IAP) Market: Solid Tumor (2017-2022) & ($ Millions)

Figure 9. CD47 (IAP) in Lymphoma

Figure 10. Global CD47 (IAP) Market: Lymphoma (2017-2022) & ($ Millions)

Figure 11. CD47 (IAP) in Others

Figure 12. Global CD47 (IAP) Market: Others (2017-2022) & ($ Millions)

Figure 13. Global CD47 (IAP) Market Size Market Share by Application in 2021

Figure 14. Global CD47 (IAP) Revenue Market Share by Player in 2021

Figure 15. Global CD47 (IAP) Market Size Market Share by Regions (2017-2022)

Figure 16. Americas CD47 (IAP) Market Size 2017-2022 ($ Millions)

Figure 17. APAC CD47 (IAP) Market Size 2017-2022 ($ Millions)

Figure 18. Europe CD47 (IAP) Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa CD47 (IAP) Market Size 2017-2022 ($ Millions)

Figure 20. Americas CD47 (IAP) Value Market Share by Country in 2021

Figure 21. Americas CD47 (IAP) Consumption Market Share by Type in 2021

Figure 22. Americas CD47 (IAP) Market Size Market Share by Application in 2021

Figure 23. United States CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC CD47 (IAP) Market Size Market Share by Region in 2021

Figure 28. APAC CD47 (IAP) Market Size Market Share by Application in 2021

Figure 29. China CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 33. India CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe CD47 (IAP) Market Size Market Share by Country in 2021

Figure 36. Europe CD47 (IAP) Market Size Market Share by Type in 2021

Figure 37. Europe CD47 (IAP) Market Size Market Share by Application in 2021

Figure 38. Germany CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 39. France CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa CD47 (IAP) Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa CD47 (IAP) Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa CD47 (IAP) Market Size Market Share by Application in 2021

Figure 46. Egypt CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country CD47 (IAP) Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 52. APAC CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 53. Europe CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 55. United States CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 56. Canada CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 57. Mexico CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 58. Brazil CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 59. China CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 60. Japan CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 61. Korea CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 63. India CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 64. Australia CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 65. Germany CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 66. France CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 67. UK CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 68. Italy CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 69. Russia CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 70. Spain CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 71. Egypt CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 72. South Africa CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 73. Israel CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 74. Turkey CD47 (IAP) Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries CD47 (IAP) Market Size 2023-2028 ($ Millions)